Details of the Drug
General Information of Drug (ID: DMEHRKA)
Drug Name |
Anti-CD20 engineered toxin bodies
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Anti-CD20 engineered toxin bodies (lymphoma); Anti-CD20 ETBs (lymphoma), Molecular Templates; Anti-CD20 engineered toxin bodies (lymphoma), Molecular Templates | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||